These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39658878)

  • 1. Fibroblast Growth Factor Receptor 4 Promotes Triple-Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling.
    Ye J; Wu S; Quan Q; Ye F; Zhang J; Song C; Fan Y; Cao H; Tang H; Zhao J
    Cancer Med; 2024 Dec; 13(23):e70439. PubMed ID: 39658878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib.
    Jonas K; Prinz F; Ferracin M; Krajina K; Pasculli B; Deutsch A; Madl T; Rinner B; Slaby O; Klec C; Pichler M
    Breast Cancer Res; 2023 Oct; 25(1):119. PubMed ID: 37803350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [GINS1 Enhances Glycolysis, Proliferation and Metastasis in Lung Adenocarcinoma Cells by Activating the Notch/PI3K/AKT/mTORC1 Signaling Pathway].
    Huo Y; Xu X; Ma X; Feng Y
    Zhongguo Fei Ai Za Zhi; 2024 Oct; 27(10):735-744. PubMed ID: 39631830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT2/SLC27A3/PINK1-Mediated Mitophagy Remodeling Lipid Metabolism Contributes to Pazopanib Resistance in Clear Cell Renal Cell Carcinoma.
    Lu D; Li Y; Niu X; Sun J; Zhan W; Shi Y; Yu K; Huang S; Liu X; Xie L; Ma X; Liu B
    Research (Wash D C); 2024; 7():0539. PubMed ID: 39600540
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of Harmaline in Inhibiting c-Myc, Altering Molecular Typing, and Promoting Apoptosis in Triple-Negative Breast Cancer.
    Xu H; Ma Y; Li H; Song X; Liu Y; Mierzhakenmu Z; Yan K; Xu R; Zhao Z; Yuan H; Dong C
    Breast Cancer (Dove Med Press); 2024; 16():855-866. PubMed ID: 39655230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifaceted impact of HIV inhibitor dapivirine on triple negative breast cancer cells reveals potential entities as targets for novel therapy.
    Patil K; Johnston E; Novack J; Wallace G; Lin M; Pai SB
    Sci Rep; 2024 Dec; 14(1):30103. PubMed ID: 39627279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclovirobuxine D inhibits triple-negative breast cancer via YAP/TAZ suppression and activation of the FOXO3a/PINK1-Parkin pathway-induced mitophagy.
    Wang ZQ; Wu ZX; Chen JW; Li HF; Wu HD; Bao JX; Cheng Y; Dai YW; Wang OC; Dai XX
    Phytomedicine; 2024 Nov; 136():156287. PubMed ID: 39615216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitors.
    Ding X; Liang J; Sharko AC; Hilimire TA; Li J; Loskutov J; Mack ZT; Ji H; Schools GP; Cai C; Pugacheva EN; Chen M; Roninson IB; Broude EV
    Proc Natl Acad Sci U S A; 2024 Nov; 121(47):e2414501121. PubMed ID: 39541354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cecal metabolomics of 2 divergently selected rabbit lines revealed microbial mechanisms correlated to intramuscular fat deposition.
    Zubiri-Gaitán A; Martínez-Álvaro M; Blasco A; Hernández P
    J Anim Sci; 2024 Jan; 102():. PubMed ID: 39497598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SULT2B1: a novel therapeutic target in colorectal cancer via modulation of AKT/PKM2-mediated glycolysis and proliferation.
    Ma J; Sun F; Li W; Du R; Liu M; Wei Q; Kang B; Yan S; Wang C
    J Transl Med; 2024 Dec; 22(1):1093. PubMed ID: 39623433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review.
    O'Leary C; Ralphs R; Stevenson J; Smith A; Harrison J; Kiss Z; Armitage H
    Campbell Syst Rev; 2024 Jun; 20(2):e1396. PubMed ID: 38645303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of malic enzyme 1 predicts adverse prognosis in patients with cytogenetically normal acute myeloid leukaemia and promotes leukaemogenesis through the IL-6/JAK2/STAT3 pathways.
    Zhang C; Li W; Wu F; Lu Z; Zeng P; Luo Z; Cao Y; Wen F; Li J; Chen X; Wang F
    Ther Adv Hematol; 2024; 15():20406207241301948. PubMed ID: 39610460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The volatile oil of Acorus tatarinowii Schott ameliorates Alzheimer's disease through improving insulin resistance via activating the PI3K/AKT pathway.
    Huang J; Xu Z; Yu C; Liu L; Ji L; Qiu P; Li C; Zhou X
    Phytomedicine; 2024 Dec; 135():156168. PubMed ID: 39486109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosmarinic acid attenuates glioblastoma cells and spheroids' growth and EMT/stem-like state by PTEN/PI3K/AKT downregulation and ERK-induced apoptosis.
    Şengelen A; Önay-Uçar E
    Phytomedicine; 2024 Dec; 135():156060. PubMed ID: 39341126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-1269a/PCDHGA9/CXCR4/β-catenin pathway promotes colorectal cancer invasion and metastasis.
    Mei H; Luo Q; Weng J; Hao J; Cai J; Zhou R; Bian C; Ye Y; Luo S; Wen Y
    Cell Mol Biol Lett; 2024 Nov; 29(1):144. PubMed ID: 39587482
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.